1 May 2023 false No description of principal activity Taxfiler 2024.6 13467459business:PrivateLimitedCompanyLtd2023-05-012024-04-30 134674592023-04-30 134674592023-05-012024-04-30 13467459business:AuditExempt-NoAccountantsReport2023-05-012024-04-30 13467459business:FilletedAccounts2023-05-012024-04-30 134674592024-04-30 13467459business:Director12023-05-012024-04-30 13467459business:RegisteredOffice2023-05-012024-04-30 134674592023-04-30 13467459core:WithinOneYear2024-04-30 13467459core:WithinOneYear2023-04-30 13467459core:ShareCapitalcore:PreviouslyStatedAmount2024-04-30 13467459core:ShareCapitalcore:PreviouslyStatedAmount2023-04-30 13467459core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-04-30 13467459core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-04-30 13467459core:PreviouslyStatedAmount2024-04-30 13467459core:PreviouslyStatedAmount2023-04-30 13467459business:SmallEntities2023-05-012024-04-30 13467459countries:EnglandWales2023-05-012024-04-30 13467459core:PlantMachinery2023-05-012024-04-30 13467459core:ComputerEquipment2023-05-012024-04-30 13467459core:IntangibleAssetsOtherThanGoodwill2023-04-30 13467459core:IntangibleAssetsOtherThanGoodwill2023-05-012024-04-30 13467459core:IntangibleAssetsOtherThanGoodwill2024-04-30 13467459core:PlantMachinery2023-04-30 13467459core:ComputerEquipment2023-04-30 13467459core:PlantMachinery2024-04-30 13467459core:ComputerEquipment2024-04-30 134674592022-05-012023-04-30 iso4217:GBP xbrli:pure
Company Registration No. 13467459 (England and Wales)
Harper Medical Technology Limited Unaudited accounts for the year ended 30 April 2024
Harper Medical Technology Limited Unaudited accounts Contents
Page
- 2 -
Harper Medical Technology Limited Company Information for the year ended 30 April 2024
Director
Dr. Vaibhav SHARMA
Company Number
13467459 (England and Wales)
Registered Office
27 Old Gloucester Street London London WC1N 3AX England
- 3 -
Harper Medical Technology Limited Statement of financial position as at 30 April 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Intangible assets
- 
11,212 
Tangible assets
- 
11,131 
- 
22,343 
Current assets
Debtors
100 
100 
Cash at bank and in hand
970 
1,902 
1,070 
2,002 
Creditors: amounts falling due within one year
- 
(1,794,068)
Net current assets/(liabilities)
1,070 
(1,792,066)
Net assets/(liabilities)
1,070 
(1,769,723)
Capital and reserves
Called up share capital
100 
100 
Profit and loss account
970 
(1,769,823)
Shareholders' funds
1,070 
(1,769,723)
For the year ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 31 January 2025 and were signed on its behalf by
Dr. Vaibhav SHARMA Director Company Registration No. 13467459
- 4 -
Harper Medical Technology Limited Notes to the Accounts for the year ended 30 April 2024
1
Statutory information
Harper Medical Technology Limited is a private company, limited by shares, registered in England and Wales, registration number 13467459. The registered office is 27 Old Gloucester Street, London, London, WC1N 3AX, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention. The financial statements are presented in sterling which is the functional currency of the company and rounded to the nearest pound.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
Straight line 5 years
Computer equipment
Straight line 5 years
Intangible fixed assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses. Patents and licences are being amortised evenly over their estimated useful life of ten years.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign exchange
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rates of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
- 5 -
Harper Medical Technology Limited Notes to the Accounts for the year ended 30 April 2024
4
Intangible fixed assets
Other 
£ 
Cost
At 1 May 2023
12,166 
Disposals
(12,166)
At 30 April 2024
- 
Amortisation
At 1 May 2023
954 
On disposals
(954)
At 30 April 2024
- 
Net book value
At 30 April 2024
- 
At 30 April 2023
11,212 
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses. Patents and licences are being amortised evenly over their estimated useful life of ten years.
5
Tangible fixed assets
Plant & machinery 
Computer equipment 
Total 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At 1 May 2023
8,146 
10,354 
18,500 
Disposals
(8,146)
(10,354)
(18,500)
At 30 April 2024
- 
- 
- 
Depreciation
At 1 May 2023
1,705 
5,664 
7,369 
On disposals
(1,705)
(5,664)
(7,369)
At 30 April 2024
- 
- 
- 
Net book value
At 30 April 2024
- 
- 
- 
At 30 April 2023
6,441 
4,690 
11,131 
6
Debtors
2024 
2023 
£ 
£ 
Amounts falling due within one year
Other debtors
100 
100 
7
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
Amounts owed to group undertakings and other participating interests
- 
1,794,068 
- 6 -
Harper Medical Technology Limited Notes to the Accounts for the year ended 30 April 2024
8
Transactions with related parties
During the financial year, the company was party to a related-party transaction with Harper Medical Limited, a company under common control of the director, Dr Vaibhav Sharma. The company had previously received a loan from Harper Medical Limited, amounting to £1,795,566.23. Due to the company’s financial position, Harper Medical Limited has impaired the full £1,795,566.23 of the outstanding loan. The impairment of the loan has been recognised as other income in the Profit and Loss Account for the year ended 30 April 2024.
9
Controlling party
The company is controlled by Harper Medical Limited which is the parent undertaking.
10
Average number of employees
During the year the average number of employees was 0 (2023: 12).
- 7 -